The growth in high-performance liquid chromatography market is driven by high sensitivity &accuracy of the HPLC technique, the growing importance of HPLC tests in drug approvals, the rising popularity of hyphenated techniques, and increasing pharmaceutical R&D spending. However, the high cost of HPLC systems is expected to restrict market growth to a certain extent.
The global high-performance
liquid chromatography market size is projected to reach USD 5.7
billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 4.6% during the
forecast period.
Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=117899209
Market Segmentation: -
Based on the product, the market was divided into instruments,
consumables, and accessories. The instrument market is subjected to account for
the largest share in the HPLC market and consumables to growth at the highest
rate during the forecast period. The need to analyze compounds in trace
concentration and the extensive use of the system in forensic institutes and
industries such as pharmaceuticals, food, nutraceuticals, cosmetics, and environmental
testing calls for growth of the segment.
Based on the application, the HPLC market is divided into
clinical research, diagnostics, forensics, and other applications. Clinical
research is subjected to grow at the highest rate in the forecast period. A
rise in pharmaceutical and biotechnological research fueled by the need for
numerous preclinical and clinical studies performed during the drug discovery
and development process is said to drive the market.
Regional Analysis:
North America is
expected to account for the largest share of the global HPLC market. Market
growth in this region is driven primarily by the increase in R&D funding,
the growing number of preclinical activities by CROs &pharmaceutical
companies, and the increasing food & agricultural industry in Canada. On the other hand,AsiaPacific is projected to have
the highest growth rate in the forecast period. The high growth rate of the
Asian region can be attributed to factors such asextensive sales of biosimilars
and generics in Japan,
and the development in the pharma and biotech sectors in India and China are
some of the major factors driving the growth of the HPLC market.
Get 10% Customization on this Research Report: -
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=117899209
Top key Players:
The global HPLC market is well established owing to the
dominance of prominent market players, such as Waters (US), Agilent (US),
Shimadzu (Japan), Thermo Fisher (US), PerkinElmer (US), GE Healthcare
(US), Bio-Rad (US), Merck Millipore (Germany),
Hitachi (Japan),
Showa Denko (Japan), Gilson (US), Phenomenex (US), JASCO (US), Hamilton Company (US), SIELC (US), Orochem
(US), YMC Co. Ltd. (Japan),
Restek (US), Trajan Scientific (Australia),
and Tosoh Bioscience LLC (Japan).
No comments:
Post a Comment